As the CEO of EpiBone, Nina Tandon leads a team of talented scientists and engineers who are working to transform the field of regenerative medicine. Their mission is to provide patients with personalized, regenerative skeletal treatments that promote healing and improve quality of life.

At EpiBone, they use adult stem cells to grow personalized bone tissue for skeletal reconstruction. Their technology has the potential to revolutionize the field of orthopedic surgery and help millions of people worldwide.

Before joining EpiBone, Nina worked as a researcher in tissue engineering and stem cell biology, studying how cells interact with each other and their environments. She received her Ph.D. in biomedical engineering and MBA in healthcare entrepreneurship from Columbia University and has been recognized for her work by Forbes, Inc. Magazine, and the World Economic Forum.

In addition to her work at EpiBone, Nina is an advocate for diversity and inclusion in STEM fields and is a frequent guest lecturer in courses at Columbia University and MIT. She is also a frequent speaker and commentator on issues related to regenerative medicine, biotech entrepreneurship, and innovation in healthcare.